C07K 14/44
From protozoa
Official title: from protozoa
C07K14/44 (From protozoa) appears on 834 US grants and 774 published applications in this corpus.
Search patents in C07K- Granted patents
- 834
- Published applications
- 774
- Assignees
- 557
- Inventors
- 1,888
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 9 | 0 |
| 1988 | 5 | 0 |
| 1989 | 9 | 0 |
| 1990 | 8 | 0 |
| 1991 | 12 | 0 |
| 1992 | 17 | 0 |
| 1993 | 27 | 0 |
| 1994 | 9 | 0 |
| 1995 | 15 | 0 |
| 1996 | 23 | 0 |
| 1997 | 44 | 0 |
| 1998 | 42 | 0 |
| 1999 | 39 | 0 |
| 2000 | 28 | 0 |
| 2001 | 28 | 4 |
| 2002 | 31 | 43 |
| 2003 | 26 | 66 |
| 2004 | 28 | 54 |
| 2005 | 24 | 45 |
| 2006 | 24 | 33 |
| 2007 | 16 | 28 |
| 2008 | 28 | 34 |
| 2009 | 24 | 41 |
| 2010 | 29 | 48 |
| 2011 | 21 | 33 |
| 2012 | 28 | 27 |
| 2013 | 16 | 30 |
| 2014 | 20 | 28 |
| 2015 | 22 | 27 |
| 2016 | 24 | 27 |
| 2017 | 27 | 25 |
| 2018 | 18 | 25 |
| 2019 | 19 | 24 |
| 2020 | 20 | 19 |
| 2021 | 15 | 29 |
| 2022 | 13 | 19 |
| 2023 | 13 | 16 |
| 2024 | 14 | 21 |
| 2025 | 12 | 16 |
| 2026 | 2 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Transmission-blocking vaccine against Babesia26 May 2026US 12,636,355 B2James Cook University
- Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host13 Jan 2026US 12,521,428 B2Institut Pasteur
- Cryptosporidiosis vaccine21 Oct 2025US 12,448,417 B2Intervet Inc.
- Synthetic plasmodium antigens, compositions, and uses thereof2 Sep 2025US 12,404,311 B2Case Western Reserve University
- Compositions comprising CelTOS immunogens and antibodies and method of use thereof26 Aug 2025US 12,398,184 B2University of South Florida
- Optimized csp variants and related methods8 Oct 2026US 2026/0308209 A1
- Liposomal formulation for treatment of visceral leishmaniasis24 Sep 2026US 2026/0284167 A1Council of Scientific and Industrial Research
- Optogenetic Actuators and Related Nucleic Acids, Constructs, Compositions, and Methods24 Sep 2026US 2026/0285922 A1Science Incorporated
- Compositions for delivery of liver stage antigens and related methods3 Sep 2026US 2026/0256898 A1BioNTech SE
- Vaccine6 Aug 2026US 2026/0224681 A1Oxford University Innovation Limited
Most cited
By later US patents
- Multiple antigen peptide system261US 5,229,490 AThe Rockefeller University · 1993
- Vaccinia DNA172US 5,017,487 AHoffmann-La Roche Inc. · 1991
- Synthetic ligation reassembly in directed evolution148US 6,537,776 B1Diversa Corporation · 2003
- Saturation mutagenesis in directed evolution147US 6,171,820 B2Diversa Corporation · 2001
- Recombinant MVA vaccinia virus120US 5,185,146 AHoffmann-LaRoche Inc. · 1993